Elutia (ELUT) Asset Writedowns and Impairment (2023 - 2024)
Elutia's (ELUT) quarterly Asset Writedowns and Impairment came in at $209000.0 in Q4 2024, up 185.66% quarter-over-quarter from -$244000.0 in Q3 2023.
Powered by 
Analysis
Elutia (ELUT) Asset Writedowns and Impairment (2023 - 2024) Analysis & Trends
Elutia has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $209000.0 for Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2023 | -244,000.00 |